Allograft Exhibits Ideal Properties For Bone Regeneration
/PRNewswire/ -- Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces that a peer review article in Dove Press Journal has determined its OsteoSponge allograft exhibits ideal properties for bone regeneration, similar to those of autografts (graft of patient's own bone) with the distinct advantage over autografts, in that there is no risk of complications at the harvest site or donor pain postoperatively. The article describes the rationale for, and characteristics of, the OsteoSponge, summarizing the results from preclinical and human studies, and includes a discussion of the strengths and limitations of different types of bone graft for the treatment of osseous defects.
"We are very pleased to share this paper with surgeons, materials managers, and distributors that not only is OsteoSponge equal to, but offers attributes even better than, the patient's own bone, for graft procedures," said Guy Cook, Bacterin's chairman and CEO. "The OsteoSponge product was and still is a revolutionary concept in the field of bone grafting and this paper is another step in validating our collective efforts."
The paper, titled, "Rationale, characteristics, and clinical performance of the OsteoSponge: a novel allograft for treatment of osseous defects," can be downloaded at the following link: http://www.dovepress.com/articles.php?article_id=9619
About OsteoSponge@ The OsteoSponge@ allograft consists of 100 percent demineralized human cancellous bone, with no additional carrier materials. The OsteoSponge is compressible, allowing precise graft placement in most osseous defects; subsequent expansion completely fills the void. The material is prepared using methods that preserve native growth factors, thereby promoting cellular ingrowth, proliferation, and ultimately osteogenesis. OsteoSponge has been used in over 100,000 procedures.